(lp0
S'Cambrex Corporation: Exciting Time Ahead For This Biotech Company Seeking Alpha - Mar 24, 2016 Several months ago, I wrote a research article on Cambrex . The company has been growing impressively and just had a record year while the stock is up about 90% since 2015.'
p1
aS"Claes Glassell Appointed to the Board of Directors of Cambrex Corporation GlobeNewswire  - Mar 16, 2016 EAST RUTHERFORD, N.J., March 16, 2016  -- Cambrex Corporation   announced today that on March 14, 2016, Claes Glassell was appointed to the Company's Board of Directors for a term expiring on the date&nbsp;..."
p2
aS'Cambrex: A Pure Growth Play Seeking Alpha - Feb 15, 2017 Cambrex provides products and services for the development and commercialization of new and generic therapeutics. They operate in North America, Europe, and Asia.'
p3
aS'55.1513 MarketWatch - Nov 12, 2010 Tfs Capital Llc Buys Cambrex Corp, Chemtura Corp, Essendant Inc, Sells Liberty TripAdvisor ... Tfs Capital Llc Buys Cambrex Corp, Chemtura Corp, Essendant Inc, Sells Liberty TripAdvisor Holdings Inc, Insight Enterprises Inc, Washington REIT. Jan. 20 ...'
p4
aS'Cambrex Corporation Completes Expansion at Iowa Facility Pharmaceutical Technology Magazine   - Jul 19, 2016 Cambrex Corporation announced on July 12, 2016 the completion and validation of a $50-million production and warehousing expansion at its cGMP Charles City, Iowa site.'
p5
aS'Watching Stock Levels for Cambrex Corporation  Baxter Review - 19 hours ago Cambrex Corporation presently has an ROIC of 0.335913. The current ROIC 5 year average is 0.121732 and the ROIC Quality ratio is currently 4.550129.'
p6
aS'Cambrex: Overblown Concerns Present Attractive Entry Opportunity Into Growing ... Seeking Alpha - Oct 3, 2016 The risk of a Gilead-driven downturn is already priced in and offers an attractive buying opportunity. Active Pharmaceutical Ingredients  volumes and outsourcing will increase, drug companies continue to favor high-quality US and European&nbsp;...'
p7
aS'Cambrex Corp.  to Acquire Privately-Held PharmaCore for ~$25M StreetInsider.com - Sep 26, 2016 Cambrex Corporation  agreed to acquire PharmaCore Inc., a privately-owned company specializing in developing, manufacturing and scaling up small molecule APIs for clinical phase projects, for approximately $25 million.Cambrex bolstering API services through $25m PharmaCore acquisition - In-PharmaTechnologist.com'
p8
aS'Cambrex Corporation  Moves Lower on Volume Spike for April 03 Equities.com - Apr 3, 2017 Cambrex Corporation  traded on unusually high volume on Apr. 03, as the stock lost 0.45% to close at $54.80. On the day, Cambrex Corporation saw 542,091 shares trade hands on 4,035 trades. Considering that the stock averages only a daily volume&nbsp;...Average Brokerage Rating Of Cambrex Corporation , Bioverativ Inc.  - The USA CommerceCambrex Corporation  Reviewed By Analysts - The De Soto Edge'
p9
aS'Why Cambrex Corporation Soared Motley Fool - Jan 29, 2014 Shares of Cambrex Corporation  soared Tuesday, up 15% for the day. News on Monday broke that the company recently passed an FDA manufacturing inspection for its plant in Iowa, and today the stock was upgraded to &quot;overweight&quot; by a&nbsp;...'
p10
a.